Biotech Business Dev & Product Strategist

Biocytogen; Madison (WI); On-site; USD 120,000 - 160,000; Full time

Benefits offered by this job

Medical Insurance

Dental Insurance

Vision Insurance

Health Reimbursement Accounts

Life and AD&D Insurance

Short & Long Term Disability Insurance

401K with Company Match

Paid Time Off

Paid Sick Days & Holidays

Job summary

Biocytogen seeks a PhD-level bioscience professional to drive science and business initiatives in immuno-oncology and related areas. You will identify and develop opportunities, engage top scientists, and negotiate contracts while representing Biocytogen at conferences and trade shows.

The role requires strong communication, a passion for biopharma, willingness to travel, and Mandarin language skills preferred. This is a growth-focused opportunity aligned with Biocytogen's expansion in the U.S.

Qualifications

• Ph.D. in bioscience with focus areas metabolic, diabetic, or pharmacology.
• Strong interest in biopharmaceutical science and business.
• Excellent written and oral communication; willingness to travel; Mandarin preferred.

Responsibilities

• Master the science and business skills in the above-mentioned fields.
• Actively reach out to prospective customers, explore business opportunities, manage negotiations and secure contracts.
• Attend trade shows/relevant conferences.
• Support the Marketing Team in branding and building awareness in the marketplace.

Skills

Communication skills

Willingness to travel

Mandarin language

Networking with scientists

Education

Ph.D. in bioscience (metabolic/diabetic/pharmacology)

Job description

Biocytogen seeks a PhD-level bioscience professional to drive science and business initiatives in immuno-oncology and related areas. You will identify and develop opportunities, engage top scientists, and negotiate contracts while representing Biocytogen at conferences and trade shows.

The role requires strong communication, a passion for biopharma, willingness to travel, and Mandarin language skills preferred. This is a growth-focused opportunity aligned with Biocytogen's expansion in the U.S.